{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:55:39Z","timestamp":1792158939013,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jdermsci.2013.06.014","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T18:46:10Z","timestamp":1373481970000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis"],"prefix":"10.1016","volume":"72","author":[{"given":"Yurong","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdermsci.2013.06.014_bib0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jnnp.70.5.569","article-title":"Progress in inflammatory myopathies: good but not good enough","volume":"70","author":"Dalakas","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.jdermsci.2013.06.014_bib0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"issue":"9388","key":"10.1016\/j.jdermsci.2013.06.014_bib0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"issue":"8540","key":"10.1016\/j.jdermsci.2013.06.014_bib0020","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(87)92271-9","article-title":"Dermatomyositis, polymyositis, and coxsackie-b-virus infection","volume":"1","author":"Bowles","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jdermsci.2013.06.014_bib0025","first-page":"90","article-title":"Coxsackie virus infection associated with myositis and polyarthritis","volume":"25","author":"G\u00f3mez Rodr\u00edguez","year":"2008","journal-title":"AN Med Interna"},{"issue":"4","key":"10.1016\/j.jdermsci.2013.06.014_bib0030","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcv.2010.08.015","article-title":"Polymyositis\/dermatomyositis and nasopharyngeal carcinoma: the Epstein\u2013Barr virus connection?","volume":"49","author":"Chen","year":"2010","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.jdermsci.2013.06.014_bib0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-2143(03)00108-2","article-title":"Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses","volume":"142","author":"Tam","year":"2003","journal-title":"J Lab Clin Med"},{"issue":"7","key":"10.1016\/j.jdermsci.2013.06.014_bib0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","article-title":"Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies","volume":"17","author":"Engel","year":"1986","journal-title":"Hum Pathol"},{"issue":"21","key":"10.1016\/j.jdermsci.2013.06.014_bib0045","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000291619.17160.b8","article-title":"Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications","volume":"69","author":"Greenberg","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jdermsci.2013.06.014_bib0050","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/art.34465","article-title":"Interleukin-1 and tumor necrosis factor \u03b1 blockade treatment of experimental polymyositis in mice","volume":"64","author":"Sugihara","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.jdermsci.2013.06.014_bib0055","first-page":"845","article-title":"Cathepsin B promoted the apoptosis of vascular smooth muscle cells as induced by tumor necrosis factor-\u03b1","volume":"91","author":"Zhang","year":"2011","journal-title":"Natl Med J China"},{"issue":"2","key":"10.1016\/j.jdermsci.2013.06.014_bib0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biochi.2007.07.024","article-title":"Cysteine cathepsins: cellular roadmap to different functions","volume":"90","author":"Brix","year":"2008","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.jdermsci.2013.06.014_bib0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000117430","article-title":"Calpain and cathepsins in the skeletal muscle of inflammatory myopathies","volume":"37","author":"Kumamoto","year":"1997","journal-title":"Eur Neurol"},{"issue":"11","key":"10.1016\/j.jdermsci.2013.06.014_bib0070","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s11064-007-9567-7","article-title":"Activation of calpain, cathepsin-b and caspase-3 during transient focal cerebral ischemia in rat model","volume":"33","author":"Chaitanya","year":"2008","journal-title":"Neurochem Res"},{"issue":"2","key":"10.1016\/j.jdermsci.2013.06.014_bib0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10495-006-3486-y","article-title":"Cathepsin-regulated apoptosis","volume":"11","author":"Chwieralski","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.jdermsci.2013.06.014_bib0080","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1038\/sj.onc.1207512","article-title":"Lysosomes in cell death","volume":"23","author":"Guicciardi","year":"2004","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.jdermsci.2013.06.014_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymeth.2007.12.001","article-title":"Apoptosis and necrosis: detection, discrimination and phagocytosis","volume":"44","author":"Krysko","year":"2008","journal-title":"Methods"},{"issue":"13","key":"10.1016\/j.jdermsci.2013.06.014_bib0090","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/jnr.22453","article-title":"Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway","volume":"88","author":"Luo","year":"2010","journal-title":"J Neurosci Res"},{"issue":"20","key":"10.1016\/j.jdermsci.2013.06.014_bib0095","first-page":"2489","article-title":"Preliminary research on the pathological role of cathepsin-B in subcutaneous heteroplastic pancreatic carcinoma in nude mice","volume":"122","author":"Zhang","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"10.1016\/j.jdermsci.2013.06.014_bib0100","first-page":"741","article-title":"Effect of cathepsin B inhibitor CA-074Me on the model of mice viral myocarditis","volume":"15","author":"Zhang","year":"2008","journal-title":"Clin Med J Chin"},{"issue":"10","key":"10.1016\/j.jdermsci.2013.06.014_bib0105","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.15.1231","article-title":"Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice","volume":"15","author":"Yan","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jdermsci.2013.06.014_bib0110","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1096\/fj.06-7924com","article-title":"Cathepsin cysteine proteases in cardiovascular disease","volume":"21","author":"Lutgens","year":"2007","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.jdermsci.2013.06.014_bib0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jdermsci.2013.06.014_bib0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jdermsci.2013.06.014_bib0125","first-page":"1012","article-title":"Preliminary study on the establishment of an animal model of experimental autoimmune polymyositis infection with coxsaekievirus B","volume":"13","author":"Wang","year":"2006","journal-title":"Clin Med J Chin"},{"issue":"6","key":"10.1016\/j.jdermsci.2013.06.014_bib0130","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.4049\/jimmunol.179.6.3772","article-title":"Attenuation of experimental autoimmune myositis by blocking ICOS-ICOS ligand interaction","volume":"179","author":"Katsumata","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jdermsci.2013.06.014_bib0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-5728(99)00087-9","article-title":"C-protein in the skeletal muscle induces severe autoimmune polymyositis in Lewis rats","volume":"98","author":"Kohyama","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0140","first-page":"52","article-title":"Effect of cathepsin B inhibitor CA-074Me on viral myocarditis in mice","volume":"23","author":"Yu","year":"2005","journal-title":"J Clin Ped"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0145","first-page":"55","article-title":"The protective effect of cathepsin B specific inhibitor Ca-074ME on cortical cerebral infarction","volume":"28","author":"Hou","year":"2012","journal-title":"J Pract Med"},{"issue":"10","key":"10.1016\/j.jdermsci.2013.06.014_bib0150","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/rheumatology\/ker218","article-title":"The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies","volume":"50","author":"Cerezo","year":"2011","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0155","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bcp.2008.07.041","article-title":"Cathepsins: key modulators of cell death and inflammatory responses","volume":"76","author":"Conus","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jdermsci.2013.06.014_bib0160","first-page":"1294","article-title":"Expression of cathepsin-b in non-neoplastic diseases: a research progress","author":"Tang","year":"2008","journal-title":"Med J China"},{"issue":"3","key":"10.1016\/j.jdermsci.2013.06.014_bib0165","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4049\/jimmunol.174.3.1729","article-title":"Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis","volume":"174","author":"Yang","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jdermsci.2013.06.014_bib0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI0214682","article-title":"Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity","volume":"110","author":"Saegusa","year":"2002","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jdermsci.2013.06.014_bib0175","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/bc.2010.035","article-title":"Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis","volume":"391","author":"Pozgan","year":"2010","journal-title":"Biol Chem"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0180","first-page":"12","article-title":"Coxsackievirus b-1 induced murine polymyositis-acute infection with active virus is required for myositis","volume":"14","author":"Ytterberg","year":"1987","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jdermsci.2013.06.014_bib0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","article-title":"Emerging roles of cysteine cathepsins in disease and their potential as drug targets","volume":"13","author":"Vasiljeva","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"1\u20132","key":"10.1016\/j.jdermsci.2013.06.014_bib0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0006-8993(01)02289-2","article-title":"A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia","volume":"901","author":"Seyfried","year":"2001","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2007.11.104","article-title":"Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain","volume":"366","author":"Anagli","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jdermsci.2013.06.014_bib0200","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jnr.20977","article-title":"Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats","volume":"84","author":"Tsubokawa","year":"2006","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2004.11.034","article-title":"Cellular localization and enzymatic activity of cathepsin B after spinal cord injury in the rat","volume":"193","author":"Ellis","year":"2005","journal-title":"J Exp Neur"},{"issue":"3","key":"10.1016\/j.jdermsci.2013.06.014_bib0210","doi-asserted-by":"crossref","first-page":"G794","DOI":"10.1152\/ajpgi.00363.2001","article-title":"Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity","volume":"283","author":"Vanacker","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0968-0004(00)01740-0","article-title":"Life-or-death decisions by the Bcl-2 protein family","volume":"26","author":"Adams","year":"2001","journal-title":"Trends Biochem Sci"},{"issue":"5381","key":"10.1016\/j.jdermsci.2013.06.014_bib0220","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","article-title":"The Bcl-2 protein family: arbiters of cell survival","volume":"281","author":"Adams","year":"1998","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.jdermsci.2013.06.014_bib0225","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","article-title":"BCL-2 family members and the mitochondria in apoptosis","volume":"13","author":"Gross","year":"1999","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.jdermsci.2013.06.014_bib0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.devcel.2011.06.017","article-title":"Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics","volume":"21","author":"Martinou","year":"2011","journal-title":"Dev Cell"},{"issue":"7 Suppl.","key":"10.1016\/j.jdermsci.2013.06.014_bib0235","first-page":"1693s","article-title":"BCL-2 gene family and the regulation of programmed cell death","volume":"59","author":"Korsmeyer","year":"1999","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.jdermsci.2013.06.014_bib0240","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1200\/JCO.1999.17.9.2941","article-title":"Dysregulation of apoptosis in cancer","volume":"17","author":"Reed","year":"1999","journal-title":"J Clin Oncol"},{"issue":"6635","key":"10.1016\/j.jdermsci.2013.06.014_bib0245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42867","article-title":"Double identity for proteins of the Bcl-2 family","volume":"387","author":"Reed","year":"1997","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jdermsci.2013.06.014_bib0250","doi-asserted-by":"crossref","first-page":"e13731","DOI":"10.1371\/journal.pone.0013731","article-title":"Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K\/Akt pathway in gliomas","volume":"5","author":"Malla","year":"2010","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jdermsci.2013.06.014_bib0255","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.10462","article-title":"Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies","volume":"28","author":"Figarella-Branger","year":"2003","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.jdermsci.2013.06.014_bib0260","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010051165","article-title":"Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis","volume":"99","author":"Kuru","year":"2000","journal-title":"Acta Neuropathol"},{"issue":"5488","key":"10.1016\/j.jdermsci.2013.06.014_bib0265","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181113002405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181113002405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T10:03:39Z","timestamp":1715681019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181113002405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0923181113002405"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2013.06.014","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2013.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}